LU79235A1 - Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern - Google Patents

Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern

Info

Publication number
LU79235A1
LU79235A1 LU79235A LU79235A LU79235A1 LU 79235 A1 LU79235 A1 LU 79235A1 LU 79235 A LU79235 A LU 79235A LU 79235 A LU79235 A LU 79235A LU 79235 A1 LU79235 A1 LU 79235A1
Authority
LU
Luxembourg
Prior art keywords
aminoalkylaethers
producing new
pyridinyl
new pyridinyl
producing
Prior art date
Application number
LU79235A
Other languages
English (en)
Inventor
G Philipsborn
W Boell
D Lenke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of LU79235A1 publication Critical patent/LU79235A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0018—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C2204/00—Features not otherwise provided for
    • A61C2204/002—Features not otherwise provided for using batteries
LU79235A 1977-03-17 1978-03-15 Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern LU79235A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772711655 DE2711655A1 (de) 1977-03-17 1977-03-17 Pyridinyl-aminoalkylaether

Publications (1)

Publication Number Publication Date
LU79235A1 true LU79235A1 (de) 1978-06-28

Family

ID=6003884

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79235A LU79235A1 (de) 1977-03-17 1978-03-15 Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern

Country Status (27)

Country Link
US (1) US4206117A (de)
JP (1) JPS53116382A (de)
AT (2) AT364360B (de)
AU (1) AU525566B2 (de)
BE (1) BE864917A (de)
CA (1) CA1108148A (de)
CH (1) CH638186A5 (de)
CS (2) CS202011B2 (de)
DD (1) DD134090A5 (de)
DE (1) DE2711655A1 (de)
DK (1) DK118578A (de)
ES (1) ES467931A1 (de)
FI (1) FI74962C (de)
FR (1) FR2383930A1 (de)
GB (1) GB1599061A (de)
GR (1) GR64096B (de)
HU (1) HU177287B (de)
IE (1) IE46484B1 (de)
IL (1) IL54265A0 (de)
IT (1) IT1093796B (de)
LU (1) LU79235A1 (de)
NL (1) NL189563C (de)
NO (1) NO150605C (de)
SE (1) SE446185B (de)
SU (2) SU799658A3 (de)
YU (2) YU63678A (de)
ZA (1) ZA781552B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474781A (en) * 1979-04-02 1984-10-02 Merck & Co., Inc. Treating hypertension with aminoalkoxypyridines
DE3008522A1 (de) * 1980-03-06 1981-09-17 Basf Ag, 6700 Ludwigshafen 4-(alpha)-cycloamino-arylmethyl-6-methyl-1,3-dihydro-furo (3,4-c) -pyridin-7-ole, ihre herstellung und verwendung
IL62602A (en) * 1980-05-19 1984-06-29 Labaz Sanofi Nv Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them
JPS588066A (ja) * 1981-07-03 1983-01-18 Otsuka Pharmaceut Co Ltd 光学活性〔ｓ〕−（−）−カルボスチリル誘導体の製造法
DE3373466D1 (de) * 1982-06-10 1987-10-15 Beecham Wuelfing Gmbh & Co Kg Amine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8603475D0 (en) * 1986-02-12 1986-03-19 Glaxo Group Ltd Chemical compounds
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
GB9012926D0 (en) * 1990-06-09 1990-08-01 Scras Pyrrolo-pyridine derivatives
ES2144403T3 (es) * 1990-11-30 2000-06-16 Otsuka Pharma Co Ltd Derivados de tiazol como inhibidores de oxigeno activo.
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US20010034357A1 (en) * 2000-02-02 2001-10-25 Nan-Horng Lin Substituted pyridine compounds useful for controlling chemical synaptic transmission
CA2521135A1 (en) * 2003-04-07 2004-10-28 Kalypsys, Inc. N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
PT3135672T (pt) * 2008-10-10 2020-04-02 Vm Discovery Inc Composições e métodos para o tratamento distúrbios de utilização de álcool, dor e outras doenças
KR101698153B1 (ko) * 2010-04-26 2017-01-23 광주과학기술원 Ｐ2ｘ1 및 ｐ2ｘ3 수용체 길항제로 사용되는 신규한 피리딘 카르복실산계 화합물, 이의 제조방법 및 이를 포함하는 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
US1881236A (en) * 1929-08-10 1932-10-04 Soc Of Chemical Ind Basic ethers of the pyridine series
US3535328A (en) * 1967-09-01 1970-10-20 Exxon Research Engineering Co Certain substituted aminothioethoxy pyridines
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR207133A1 (es) * 1973-02-20 1976-09-15 Ciba Geigy Ag Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano
US4073909A (en) * 1973-10-08 1978-02-14 Sandoz Ltd. Isoquinoline compounds
CH594626A5 (de) 1974-05-14 1978-01-13 Ciba Geigy Ag
CH614711A5 (de) * 1975-04-08 1979-12-14 Sandoz Ag
GB1504424A (en) * 1975-08-09 1978-03-22 Beecham Group Ltd Isoquinoline-derived aminoethers
GB1485919A (en) 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
US4060601A (en) * 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines

Also Published As

Publication number Publication date
FI74962B (fi) 1987-12-31
DK118578A (da) 1978-09-18
SE7802927L (sv) 1978-09-18
SE446185B (sv) 1986-08-18
HU177287B (en) 1981-09-28
GB1599061A (en) 1981-09-30
CH638186A5 (de) 1983-09-15
NO150605C (no) 1984-11-14
YU63678A (en) 1983-01-21
ZA781552B (en) 1979-04-25
NO780931L (no) 1978-09-19
SU799658A3 (ru) 1981-01-23
AT364360B (de) 1981-10-12
AU525566B2 (en) 1982-11-11
IT1093796B (it) 1985-07-26
JPS6123790B2 (de) 1986-06-07
SU850002A3 (ru) 1981-07-23
DE2711655C2 (de) 1987-07-16
ATA84080A (de) 1981-03-15
NO150605B (no) 1984-08-06
DE2711655A1 (de) 1978-09-21
FI780842A (fi) 1978-09-18
CA1108148A (en) 1981-09-01
IT7821099A0 (it) 1978-03-10
FI74962C (fi) 1988-04-11
JPS53116382A (en) 1978-10-11
CS202011B2 (en) 1980-12-31
FR2383930B1 (de) 1982-10-22
ATA187878A (de) 1981-03-15
CS202012B2 (en) 1980-12-31
YU225282A (en) 1983-02-28
IE780503L (en) 1978-09-17
GR64096B (en) 1980-01-22
DD134090A5 (de) 1979-02-07
BE864917A (fr) 1978-09-15
NL189563C (nl) 1993-05-17
NL189563B (nl) 1992-12-16
IL54265A0 (en) 1978-06-15
AU3419578A (en) 1979-09-20
FR2383930A1 (fr) 1978-10-13
US4206117A (en) 1980-06-03
IE46484B1 (en) 1983-06-29
NL7802719A (nl) 1978-09-19
AT364361B (de) 1981-10-12
ES467931A1 (es) 1979-07-01
YU41016B (en) 1986-10-31

Similar Documents

Publication Publication Date Title
AT366361B (de) Verfahren zur herstellung neuer 2-aminotetraline
AT362363B (de) Verfahren zur herstellung neuer azetidinole
AT351510B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
AT373251B (de) Verfahren zur herstellung neuer d-6-n-propylergoline
LU79235A1 (de) Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern
ATA557078A (de) Verfahren zur herstellung neuer 2-formylchinoxalin-1,4-dioxid-zyanacetylhydrazo e
ATA246780A (de) Verfahren zur herstellung neuer pyrazinobenzodiazepine
AT360553B (de) Verfahren zur herstellung neuer nitroso- harnstoffverbindungen
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
DD132438A5 (de) Verfahren zur herstellung neuer kortikoide
PT71116A (de) Verfahren zur herstellung neuer cyclobutandicarbonsaureimide
DD138211A5 (de) Verfahren zur herstellung neuer aminopyrimidin-verbindungen
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT360998B (de) Verfahren zur herstellung neuer n-pyrimidinyl- -imidsaeureester
AT367018B (de) Verfahren zur herstellung neuer indene
AT360971B (de) Verfahren zur herstellung neuer alkinole
AT362063B (de) Verfahren zur herstellung neuer spectinomycin- derivate
ATA590179A (de) Verfahren zur herstellung neuer 2-aminotetraline
PT67639A (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
ATA464778A (de) Verfahren zur herstellung neuer indanderivate
DD131169A5 (de) Verfahren zur herstellung neuer azatetracyclen
AT373240B (de) Verfahren zur herstellung neuer pyridyloxyphenoxyalkancarbonsaeurederivate
ATA269880A (de) Verfahren zur herstellung neuer pyridinderivate